# OCULAR THERAPEUTIX INC (OCUL)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/OCUL/

- Reporting holders: 5
- Reported value: $192.2K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [FINANCIAL MANAGEMENT NETWORK INC](https://holderbook.com/funds/1844831-financial-management-network-inc/) | $153.1K | 22,000 | 0.0% | 3 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $15.4K | 2,012 | 0.0% | 11 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $14.7K | 1,916 | 0.0% | 9 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $5.6K | 735 | 0.0% | 7 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $3.3K | 435 | 0.0% | 9 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $192.2K |
| Q2 2026 | 266 | $2.2B |
| Q1 2026 | 273 | $1.8B |
| Q4 2025 | 254 | $2.4B |
| Q3 2025 | 221 | $2.2B |
| Q2 2025 | 189 | $1.5B |
| Q1 2025 | 198 | $1.0B |
| Q4 2024 | 181 | $1.2B |
| Q3 2024 | 167 | $1.2B |
| Q2 2024 | 149 | $992.2M |
| Q1 2024 | 147 | $1.2B |
| Q4 2023 | 118 | $335.6M |